Protocol - Psoriatic Arthritis (PsA) - Impact of Disease
Description
A self-report adult questionnaire including 12 Likert-style questions.
Specific Instructions
None
Availability
Protocol
We want you to indicate how much your psoriatic arthritis impacts your health.
Please tell us how you have been feeling this last week.
- Pain
Circle the number that best describes the pain you felt due to your psoriatic arthritis during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 3 = [ ] |
- Fatigue
Circle the number that best describes the overall level of fatigue due to your psoriatic arthritis you have experienced during the last week:
No fatigue | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Totally Exhausted | For office use only: |
Result x 2 = [ ] |
- Skin problems
Circle the number that best describes the skin problems including itching you felt due to your psoriatic arthritis during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Work and/or leisure activities
Circle the number that best describes the difficulties you had to participate fully in work and/or leisure activities due to your psoriatic arthritis during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Functional capacity
Circle the number that best describes the difficulty you had in doing daily physical activities due to your psoriatic arthritis during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Discomfort
Circle the number that best describes the feeling of discomfort and annoyance with everyday tasks due to your psoriatic arthritis during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Sleep disturbance
Circle the number that best describes the sleep difficulties (i.e., resting at night) you felt due to your psoriatic arthritis during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Coping
Considering your psoriatic arthritis overall, how well did you cope (manage, deal, make do) with your psoriatic arthritis during the last week?
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Anxiety, fear, and uncertainty
Circle the number that best describes the level of anxiety, fear, and uncertainty (for example, about the future, treatments, fear of loneliness) due to your psoriatic arthritis you have experienced during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Embarrassment and/or shame
Considering your psoriatic arthritis overall, circle the number that best describes the level of embarrassment and/or shame due to your appearance experienced during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Social participation
Circle the number that best describes the difficulties you had to participate fully in social activities (including relationships with family and/or people very close to you) due to your psoriatic arthritis during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
- Depression
Circle the number that best describes the level of depression due to your psoriatic arthritis you have experienced during the last week:
None | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Extreme | For office use only: |
Result x 2 = [ ] |
Thank you for Answering This Questionnaire
Final Psoriatic Arthritis Impact of Disease (PsAID) out of 20: Add up the [ ] and divide by 10: _______________
PsAID12 SCORING AND CALCULATION RULES
The PsAID is calculated based on 12 Numerical rating scales (NRS) questions. Each NRS is assessed as a number between 0 and 10.
Calculation
PsAID final value =
(PsAID1 (pain) NRS value (range 0-10) x 3)
+ (PsAID2 (fatigue) NRS value (range 0-10) x 2)
+ (PsAID3 (skin) NRS value (range 0-10) x 2)
+ (PsAID4 (Work and/or leisure activities) NRS value (range 0-10) x 2)
+ (PsAID5 (function) NRS value (range 0-10) x 2)
+ (PsAID6 (discomfort) NRS value (range 0-10) x 2)
+ (PsAID7 (sleep) NRS value (range 0-10) x 2)
+ (PsAID8 (coping) NRS value (range 0-10) x 1)
+ (PsAID9 (anxiety) NRS value (range 0-10) x 1)
+ (PsAID10 (embarrassment) NRS value (range 0-10) x 1)
+ (PsAID11 (social life) NRS value (range 0-10) x 1)
+ (PsAID12 (depression) NRS value (range 0-10) x 1)
The total is divided by 20.
Thus, the range of the final PsAID value is 0-10 where higher figures indicate worse status.
Missing data imputation
If one of the 12 NRS values composing the PsAID is missing, the imputation is as follows:
calculate the mean value of the 11 other (non-missing) NRS (range, 0-10) impute this value for the missing NRS.
Then, calculate the PsAID as explained above.
If 2 or more of the NRS are missing, the PsAID is considered as missing value (no imputation).
Personnel and Training Required
None
Equipment Needs
None
Requirements
| Requirement Category | Required |
|---|---|
| Major equipment | No |
| Specialized training | No |
| Specialized requirements for biospecimen collection | No |
| Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Adult, Senior
Participants
Outpatients seen for psoriatic arthritis (PsA) in the rheumatology departments of the participating tertiary care centers.
Selection Rationale
Knowing the patient’s perception of his or her life (vs. only clinician assessment) is key for understanding the real impact of psoriatic arthritis (PsA). The PsAID is a widely used and validated instrument assessing the patient’s perception in 12 areas (e.g., mood, sleep, and social participation).
Language
English, Spanish, Other languages available at source
Standards
| Standard | Name | ID | Source |
|---|
Derived Variables
None
Process and Review
Not applicable.
Protocol Name from Source
European Alliance of Associations for Rheumatology (EULAR) Psoriatic Arthritis Impact of Disease: PsAID12 for Clinical Practice
Source
Gossec, L., de Wit, M., Kiltz, U., Braun, J., Kalyoncu, U., Scrivo, R., . . . Kvien, T. K.; EULAR PsAID Taskforce. (2014). A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: Elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Annals of the Rheumatic Diseases, 73, 1012–1019. https://pubmed.ncbi.nlm.nih.gov/24790067/
General References
da Cruz Ribeiro e Souza, E., da Silva Carneiro, S. C., Yazbek, M. A., de Cássia Menin, R., Campanholo, C. B., Carneiro, J. N., . . . Ranza, R. (2020). Validation and clinical interpretability of PsAID—Psoriatic arthritis impact of disease. Advances in Rheumatology, 60, 49. https://doi.org/10.1186/s42358-020-00149-1
Holland, R., Tillett, W., Ogdie, A., Leung, Y. Y., Gladman, D. D., Duffin, K. C., . . . Orbai, A.-M. (2018). Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 annual meeting. Journal of Rheumatology. Supplement, 94, 17–25.
https://pubmed.ncbi.nlm.nih.gov/29858348/
Orbai, A.-M., Ogdie, A., Gossec, L., Tippett, W., Leung, Y. Y., Gao, J., . . . Coates, L. C. (2020). Effect of filgotinib on health-related quality of life in active psoriatic arthritis: A randomized phase 2 trial (EQUATOR). Rheumatology (Oxford), 59(7), 1495–1504. https://pubmed.ncbi.nlm.nih.gov/31624837/
Protocol ID
172001
Variables
Export Variables| Variable Name | Variable ID | Variable Description | dbGaP Mapping | |
|---|---|---|---|---|
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Anxiety_Fear_Uncertainty | ||||
| PX172001090000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Coping | ||||
| PX172001080000 | Considering your psoriatic arthritis more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Depression | ||||
| PX172001120000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Discomfort | ||||
| PX172001060000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Embarrassment_Shame | ||||
| PX172001100000 | Considering your psoriatic arthritis more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Fatigue | ||||
| PX172001020000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Functional_Capacity | ||||
| PX172001050000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Pain | ||||
| PX172001010000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Skin_Problems | ||||
| PX172001030000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Sleep_Disturbance | ||||
| PX172001070000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Social_Participation | ||||
| PX172001110000 | Circle the number that best describes the more | N/A | ||
| PX172001_Psoriatic_Arthritis_Impact_of_Disease_Work_Leisure_Activities | ||||
| PX172001040000 | Circle the number that best describes the more | N/A | ||
Measure Name
Psoriatic Arthritis (PsA) - Impact of Disease
Release Date
October 21, 2022
Definition
A 12-item questionnaire for the participant to self-assess the impact of psoriatic arthritis on the person’s life.
Purpose
This measure can be used to determine the level of impact of psoriatic arthritis (PsA) on various areas of an individual’s life (e.g., pain, mood, sleep). PsA can be associated with decreases in quality of life and productivity and an increase in risk for cardiovascular disease and depression.
Keywords
Psoriatic arthritis, PSA, European Alliance of Associations for Rheumatology, EULAR, EULAR Psoriatic Arthritis Impact of Disease: PsAID12 for Clinical Practice, PsAID12, bone and joint
Measure Protocols
| Protocol ID | Protocol Name |
|---|---|
| 172001 | Psoriatic Arthritis (PsA) - Impact of Disease |
Publications
There are no publications listed for this protocol.